0000899243-20-005917.txt : 20200226
0000899243-20-005917.hdr.sgml : 20200226
20200226171257
ACCESSION NUMBER: 0000899243-20-005917
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200127
FILED AS OF DATE: 20200226
DATE AS OF CHANGE: 20200226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZEIN YOUSSEF EL
CENTRAL INDEX KEY: 0001193366
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 20657042
MAIL ADDRESS:
STREET 1: HYBRIDON INC
STREET 2: 345 VASSAR STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Umari Abude
CENTRAL INDEX KEY: 0001783582
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 20657043
MAIL ADDRESS:
STREET 1: STARCO CTR, BLOC B, 3RD FLOOR
STREET 2: OMAR DAUOK STREET
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pillar Partners Foundation, L.P.
CENTRAL INDEX KEY: 0001783583
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 20657044
BUSINESS ADDRESS:
STREET 1: STARCO CTR, BLOC B, 3RD FLOOR
STREET 2: OMAR DAUOK STREET
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
BUSINESS PHONE: 961 1 363 362
MAIL ADDRESS:
STREET 1: STARCO CTR, BLOC B, 3RD FLOOR
STREET 2: OMAR DAUOK STREET
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pillar Pharmaceuticals 6, L.P.
CENTRAL INDEX KEY: 0001783584
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 20657045
BUSINESS ADDRESS:
STREET 1: STARCO CTR, BLOC B, 3RD FLOOR
STREET 2: OMAR DAUOK STREET
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
BUSINESS PHONE: 961 1 363 362
MAIL ADDRESS:
STREET 1: STARCO CTR, BLOC B, 3RD FLOOR
STREET 2: OMAR DAUOK STREET
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pillar Pharmaceuticals V LP
CENTRAL INDEX KEY: 0001687312
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 20657046
BUSINESS ADDRESS:
STREET 1: PILLAR PHARMACEUTICALS V LP
STREET 2: OMAR DAOUK STREET
CITY: BEIRUT
STATE: E9
ZIP: 02210
BUSINESS PHONE: 617-570-1496
MAIL ADDRESS:
STREET 1: PILLAR PHARMACEUTICALS V LP
STREET 2: OMAR DAOUK STREET
CITY: BEIRUT
STATE: E9
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pillar Pharmaceuticals IV, L.P.
CENTRAL INDEX KEY: 0001588130
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 20657047
BUSINESS ADDRESS:
STREET 1: STARCO CENTER, BLOC B, THIRD FLOOR
STREET 2: OMAR DAOUK STREET
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
BUSINESS PHONE: 961 1 363 362
MAIL ADDRESS:
STREET 1: STARCO CENTER, BLOC B, THIRD FLOOR
STREET 2: OMAR DAOUK STREET
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pillar Pharmaceuticals III, L.P.
CENTRAL INDEX KEY: 0001576891
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 20657048
BUSINESS ADDRESS:
STREET 1: STARCO CENTER, BLOC B, THIRD FLOOR
STREET 2: OMAR DAOUK STREET
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
BUSINESS PHONE: 961 1 363 362
MAIL ADDRESS:
STREET 1: STARCO CENTER, BLOC B, THIRD FLOOR
STREET 2: OMAR DAOUK STREET
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pillar Pharmaceuticals II, L.P.
CENTRAL INDEX KEY: 0001562069
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 20657049
BUSINESS ADDRESS:
STREET 1: STARCO CENTER BLOC B, THIRD FLOOR
STREET 2: OMAR DAOUK STREET
CITY: BEIRUT 2020-3313
STATE: M8
ZIP: 2020-3313
BUSINESS PHONE: 9611363362
MAIL ADDRESS:
STREET 1: STARCO CENTER BLOC B, THIRD FLOOR
STREET 2: OMAR DAOUK STREET
CITY: BEIRUT 2020-3313
STATE: M8
ZIP: 2020-3313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pillar Pharmaceuticals I LP
CENTRAL INDEX KEY: 0001534425
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 20657050
BUSINESS ADDRESS:
STREET 1: C/O PILLAR INVEST OFFSHORE SAL
STREET 2: STARCO CENTER BLOC B FL3, OMAR DAOUK ST
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
BUSINESS PHONE: 0119611363362
MAIL ADDRESS:
STREET 1: C/O PILLAR INVEST OFFSHORE SAL
STREET 2: STARCO CENTER BLOC B FL3, OMAR DAOUK ST
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pillar Invest Corp
CENTRAL INDEX KEY: 0001534428
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 20657051
BUSINESS ADDRESS:
STREET 1: C/O PILLAR INVEST OFFSHORE SAL
STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
BUSINESS PHONE: 0119611363362
MAIL ADDRESS:
STREET 1: C/O PILLAR INVEST OFFSHORE SAL
STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000861838
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043072298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 EAGLEVIEW BOULEVARD
STREET 2: SUITE 212
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 4843481600
MAIL ADDRESS:
STREET 1: 505 EAGLEVIEW BOULEVARD
STREET 2: SUITE 212
CITY: EXTON
STATE: PA
ZIP: 19341
FORMER COMPANY:
FORMER CONFORMED NAME: HYBRIDON INC
DATE OF NAME CHANGE: 19951211
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-27
1
0000861838
IDERA PHARMACEUTICALS, INC.
IDRA
0001534428
Pillar Invest Corp
PILLAR INVEST OFFSHORE SAL STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
0
0
1
0
0001534425
Pillar Pharmaceuticals I LP
PILLAR INVEST OFFSHORE SAL STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
0
0
1
0
0001562069
Pillar Pharmaceuticals II, L.P.
PILLAR INVEST OFFSHORE SAL, STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
0
0
1
0
0001576891
Pillar Pharmaceuticals III, L.P.
PILLAR INVEST OFFSHORE SAL STARCO CTR,
BLOC B, 3RD FLOOR OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
0
0
1
0
0001588130
Pillar Pharmaceuticals IV, L.P.
PILLAR INVEST OFFSHORE SAL STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
0
0
1
0
0001687312
Pillar Pharmaceuticals V LP
PILLAR INVEST OFFSHORE SAL STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
0
0
1
0
0001783584
Pillar Pharmaceuticals 6, L.P.
PILLAR INVEST OFFSHORE SAL STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
0
0
1
0
0001783583
Pillar Partners Foundation, L.P.
PILLAR INVEST OFFSHORE SAL STARCO CTR
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
0
0
1
0
0001783582
Umari Abude
PILLAR INVEST OFFSHORE SAL STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
0
0
1
0
0001193366
ZEIN YOUSSEF EL
PILLAR INVEST OFFSHORE SAL, STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
0
0
1
0
Common Stock
2020-01-27
4
S
0
15000
1.77
D
3284224
I
See Footnote
Common Stock
2020-01-28
4
S
0
12532
1.762
D
3271692
I
See Footnote
Common Stock
2020-01-29
4
S
0
17250
1.7645
D
3254442
I
See Footnote
Shares sold by Pillar Pharmaceuticals I, L.P. ("Pillar I"). Pillar Invest Corporation ("Pillar GP") disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar I and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar I. Following this transaction, Pillar I owns directly 21,100 shares of common stock of the Issuer.
The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $1.76-$1.77. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Shares sold by Pillar Pharmaceuticals II, L.P. ("Pillar II"). Pillar Invest Corporation ("Pillar GP") disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. Following this transaction, Pillar II owns directly 20,820 shares of common stock of the Issuer.
The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $1.76-$1.7707. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Shares sold by Pillar Pharmaceuticals III, L.P. ("Pillar III"). Pillar Invest Corporation ("Pillar GP") disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar III and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar III. Following the transactions on 1/28/20 and 1/29/20, Pillar III owns directly 29,998 shares of common stock of the Issuer.
Shares sold by Pillar Pharmaceuticals V, L.P. ("Pillar V"). Pillar Invest Corporation ("Pillar GP") disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar V and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar V. Following this transaction, Pillar V owns directly 25,000 shares of common stock of the Issuer.
Pillar Invest Corporation, /s/ Youssef El Zein, Authorized Person
2020-02-26